Casodex/Zoladex Biomarkers in Localised Prostate Cancer
Status:
Completed
Trial end date:
2006-11-01
Target enrollment:
Participant gender:
Summary
To evaluate anti-androgen (bicalutamide) induced biological and molecular changes in prostate
comparison to chemical castration induced (goserelin) ones